Company
Biostax Corp. (0001559356)
Standardized SEC financial data for Biostax Corp. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001559356 · Pharmaceutical Preparations.
Revenue growth (YoY)
3177.5%
Return on equity
52.2%
Free cash flow
-$410K
Current ratio
0.01×
EPS (diluted)
$-0.03
Ratios for fiscal year 2018, standardized from SEC filings.
Income statement
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Revenue | $114K | — | — | — | — | — |
| Cost of revenue |
Balance sheet
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6K | $5K | $10K | $494K | $150K | $30K |
| Inventory |
Cash flow
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$1.4M | -$934 | -$192K | -$232K | -$582K | -$408K |
| Capital expenditures |
Get 0001559356 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001559356/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001559356/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"